I think there is no doubt, as you say, that had the sample size been larger, and had there been no existing claims made prior to a peer review process, the credibility of the Zicam product could have been greatly enhanced. I certainly can't disagree with the two basic points you made.
On the other hand, how many people in the sample would satisfy, Bengalus?...Come on! This is an OTC medication. If this product really works, who really cares about the peer review process...
This product will sink or swim on three things: Does it work, can the company effectively market it, and how does the competition stack up....Bengalus' tiresome tirade of technicalities, will come to an end only when we ignore him....If his arguments have any merit, which I doubt, all will come to light in due course.
Noone should bet the farm on any company, other than, perhaps, those who work for it. If there is anyone out there who has purchased an inordinate amount of their net worth of this company then perhaps you should heed Bengalus' advice and lighten up.
One caveat: I do not think his postings are humanitarian in nature.
Mike |
